This independent assessment confirms Cagrilintide 4mg from Polaris Peptides at 99.958% purity. The analysis was conducted by Janoshik Labs on March 29, 2024.
Cagrilintide is a GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.958% indicates pharmaceutical-grade synthesis with exceptional purity.
The full certificate of analysis is available for download and verification using key JJ3VTA858W7N at www.janoshik.com.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.